Regulation of human mast cell and basophil function by cAMP

General Pharmacology

Volumn 31, Issue 5, 1998, Pages 715-719

  Weston, Marie C ^a   Peachell, Peter T ^a  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

Author keywords

2 adrenoceptor agonists; Basophils; cAMP; Mast cells; Phosphodiesterase; Theophylline

Indexed keywords

ADENYLATE CYCLASE; CYCLIC AMP; ISOBUTYLMETHYLXANTHINE; ISOPRENALINE; PHOSPHODIESTERASE INHIBITOR; PHOSPHODIESTERASE IV; PROSTAGLANDIN E2; THEOPHYLLINE;

ALLERGIC DISEASE; ASTHMA; BASOPHIL; HUMAN; INFLAMMATION; MAST CELL; NONHUMAN; PRIORITY JOURNAL; REVIEW;

ADRENERGIC BETA-AGONISTS; ANIMALS; ASTHMA; BASOPHILS; CYCLIC AMP; HUMANS; MAST CELLS; PHOSPHODIESTERASE INHIBITORS; RECEPTORS, ADRENERGIC, BETA-2; SIGNAL TRANSDUCTION;

EID: 0032211980     PISSN: 03063623     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-3623(98)00080-9     Document Type: Review

References (70)

1. Andersson R.G.G., Colldahl H. Relationship between antigen-induced histamine release and cyclic AMP level in human leukocytes. Acta Allergologica. 29:1974;248-255.
2. Assem E.S.K., Schild H.O. Beta-adrenergic receptors concerned with the anaphylactic mechanism. Int. Arch. Allergy Appl. Immunol. 45:1969;62-69.
3. Barnes P.J. Cyclic nucleotides and phosphodiesterases and airway function. Eur. Respir. J. 8:1995;457-462.
4. 2-adrenoceptor agonists in asthma. Trends Pharmac. Sci. 13:1992;20-23.
5. Barnes P.J., Greening A.P., Neville L., Timmers J., Poole G.W. Single dose slow-release aminophylline at night prevents nocturnal asthma. Lancet. 1:1982;299-301.
6. Beavo J.A., Conti M., Heaslip R.J. Multiple cyclic nucleotide phosphodiesterases. Mol. Pharmac. 46:1994;399-405.
7. Beavo J.A., Reifsneider D.H. Primary sequence of cyclic nucleotide phosphodiesterase isozymes and the design of selective inhibitors. Trends Pharmacol. Sci. 11:1990;150-155.
8. Bourne H.R., Lichtenstein L.M., Melmon K.L. Pharmacologic control of allergic histamine release in vitro. Evidence for an inhibitory role of 3′5′-adenosine monophosphate in human leukocytes J. Immunol. 108:1972;695-705.
9. Burt D.S., Stanworth D.R. Changes in cellular levels of cyclic AMP in rat mast cells during secretion of histamine induced by immunoglobulin E decapeptide and ACTH (1-24) peptide. comparison with immunological and ionophore triggers Biochim. Biophys. Acta. 762:1983;458-465.
10. Butchers P.R., Skidmore I.F., Vardey C.J., Wheeldon A. Characterisation of the receptor mediating the anti-anaphylactic activities of β-adrenoceptor agonists in human lung tissue in vitro. Br. J. Pharmac. 71:1980;663-667.
11. Butchers P.R., Vardey C.J., Johnson M. Salmeterol. a potent and long-acting inhibitor of inflammatory mediator release from human lung Br. J. Pharmac. 104:1991;672-676.
12. Chong L.K., Cooper E., Vardey C.J., Peachell P.T. Salmeterol inhibition of mediator release from human lung mast cells by β-adrenoceptor-dependent and independent mechanisms. Br. J. Pharmac. 123:1998;1009-1015.
13. 2-adrenoceptor-mediated responses in human lung mast cells. Br. J. Pharmac. 121:1997;717-722.
14. Chong L.K., Morice A.H., Yeo W.W., Schleimer R.P., Peachell P.T. Functional desensitization of β agonist responses in human lung mast cells. Am. J. Respir. Cell Mol. Biol. 13:1995;540-546.
15. Church M.K., Hiroi J. Inhibition of IgE-dependent histamine release from human dispersed lung mast cells by anti-allergic drugs and salbutamol. Br. J. Pharmac. 90:1987;421-429.
16. Cockcroft D.W., McParland C.P., Britto S.A., Swystun V.A., Rutherford B.C. Regular inhaled salbutamol and airway responsiveness to allergen. Lancet. 342:1993;833-837.
17. Dent G., Giembycz M.A., Rabe K.F., Barnes P.J. Inhibition of eosinophil cyclic nucleotide PDE activity and opsonised zymosan-stimulated respiratory burst by 'type IV'-selective PDE inhibitors. Br. J. Pharmac. 103:1991;1339-1346.
18. Flower R.J. Lipocortin and the mechanism of action of the glucocorticoids. Br. J. Pharmacol. 94:1988;987-1015.
19. Fuller R.W., O'Malley G., Baker A.J., MacDermot J. Human alveolar macrophage activation. inhibition by forskolin but not betaadrenoceptor stimulation or phosphodiesterase inhibition Pulm. Pharmac. 1:1988;101-106.
20. 2-adrenoceptor agonists in asthma. Trends Pharmac. Sci. 17:1996;331-336.
21. Grainger J., Woodman K., Pearce N., Crane J., Burgess C., Keane A., Beasley R. Prescribed fenoterol and death from asthma in New Zealand, 1981-7. a further case-control study Thorax. 46:1991;105-111.
22. Holgate S.T., Hardy C., Robinson C., Agius R.M., Howarth P.H. The mast cell as a primary effector cell in the pathogenesis of asthma. J. Allergy Clin. Immunol. 79:1986;274-282.
23. Holgate S.T., Lewis R.A., Austen K.F. Role of adenylate cyclase in immunologic release of mediators from rat mast cells. agonist and antagonist effects of purine and ribose modified adenosine analogs Proc. Natl. Acad. Sci. 77:1980;6800-6806.
24. Ishizaka T., Conrad D.H., Schulman E.S., Sterk A.R., Ishizaka K. Biochemical analysis of initial triggering events of IgE-mediated histamine release from human lung mast cells. J. Immunol. 130:1983;2357-2362.
25. Ishizaka T., Ishizaka K. Activation of mast cells for mediator release through IgE receptors. Prog. Allergy. 34:1984;188-235.
26. Ishizaka T., Ishizaka K., Orange R.P., Austen K.F. The capacity of human immunoglobulin E to mediate the release of histamine and slow reacting substance of anaphylaxis (SRS-A) from monkey lung. J. Immunol. 104:1970;335-343.
27. Kay A.B. Asthma and inflammation. J. Allergy Clin. Immunol. 87:1991;893-910.
28. Lagunoff D. The role of mast cells in asthma. Exp. Lung Res. 4:1983;121-135.
29. 2-adrenoceptor agonists on mast cells of rat, guinea pig, and human. Int. Arch. Allergy Appl. Immunol. 105:1994;177-180.
30. Leoutsakos A., Truneh A., Pearce F.L. Role of cyclic AMP in the induction of histamine secretion from mast cells. Agents Actions. 16:1985;126-128.
31. Lichtenstein L.M., Gillespie E., Bourne H.R., Henney C.S. The effects of a series of prostaglandins on in vitro models of the allergic response and cellular immunity. Prostaglandins. 2:1972;519-528.
32. Lichtenstein L.M., Margolis S. Histamine release in vitro. inhibition by catecholamines and methylxanthines Science. 161:1968;902-903.
33. Lichtenstein L.M., Sobotka A.K., Malveaux F.J., Gillespie E. IgE-induced changes in human basophil cyclic AMP levels. Int. Arch. Allergy Appl. Immunol. 56:1978;473-478.
34. MacGlashan D.W. Jr., Lichtenstein L.M. The purification of human basophils. J. Immunol. 124:1980;2519-2521.
35. MacGlashan D.W. Jr., Schleimer R.P., Peters S.P., Schulman E.S., Adams G.K., Kagey-Sobotka A., Newball H.H., Lichtenstein L.M. Comparative studies of human basophils and mast cells. Fed. Proc. 42:1983;2504-2508.
36. Marone G., Ambrosio G., Bonaduce D., Genovese A., Triggiani M., Condorelli M. Inhibition of IgE-mediated histamine release from human basophils and mast cells by fenoterol. Int. Arch. Allergy Appl. Immunol. 74:1984;356-361.
37. Milgrom H., Bender B. Current issues in the use of theophylline. Am. Rev. Respir. Dis. 147:1993;S33-S39.
38. Newhouse M.T. Is theophylline obsolete? Chest. 98:1990;1-3.
39. Nicholson C.D., Shahid M. Inhibitors of cyclic nucleotide phosphodiesterase isoenzymes - their potential utility in the therapy of asthma. Pulmon. Pharmac. 7:1994;1-18.
40. Nielson C.P., Vestal R.E., Sturm R.J., Heaslip R. Effects of selective phosphodiesterase inhibitors on the polymorphonuclear leukocyte respiratory burst. J. Allergy Clin. Immunol. 86:1990;801-808.
41. 2-agonists in asthma. N. Engl. J. Med. 327:1992;1204-1208.
42. Orange R.P., Austen W.G., Austen K.F. Immunological release of histamine and slow reacting substance of anaphylaxis from human lung. I. Modulation by agents influencing cellular levels of cyclic 3′5′-adenosine monophosphate. J. Exp. Med. 134:1971;136-148.
43. Pauwels R., Persson C.G.A. Xanthines. Kaliner M.A., Barnes P.J., Persson C.G.A. Asthma. its pathology and treatment:1991;503-521 Marcel Dekker, New York.
44. Peachell P.T., MacGlashan D.W., Lichtenstein L.M., Schleimer R.P. Regulation of human basophil and lung mast cell function by cAMP. J. Immunol. 140:1988;571-579.
45. Peachell P.T., Undem B.J., Schleimer R.P., MacGlashan D.W., Lichtenstein L.M., Cieslinski L.B., Torphy T.J. Preliminary identification and role of phosphodiesterase isozymes in human basophils. J. Immunol. 148:1992;2503-2510.
46. Persson C.G.A. Xanthines as anti-inflammatory drugs. J. Allergy Clin. Immunol. 81:1988;615-617.
47. Robicsek S.A., Blanchard D.K., Djeu J.Y., Krzanowski J.J., Szentivanyi A., Polson J.B. Multiple high-affinity cyclic AMP phosphodiesterases in human T-lymphocytes. Biochem. Pharmac. 42:1991;869-877.
48. Schild H. Histamine release in anaphylactic shock of isolated lungs of guinea pigs. Quart. J. Exp. Physiol. 26:1937;165-179.
49. Schleimer R.P., Lichtenstein L.M., Gillespie E. Inhibition of basophil histamine release by anti-inflammatory steroids. Nature. 292:1981;454-455.
50. Schleimer R.P., Schulman E.S., MacGlashan D.W., Peters S.P., Hayes E.C., Adams G.K., Lichtenstein L.M., Adkinson N.F. Effects of dexamethasone on mediator release from human lung fragments and purified human lung mast cells. J. Clin. Invest. 71:1983;1830-1835.
51. Schroeder J.T., Kagey-Sobotka A., Lichtenstein L.M. The role of the basophil in allergic inflammation. Allergy. 50:1995;463-472.
52. Schulman E.S., MacGlashan D.W., Peters S.P., Schleimer R.P., Newball H.H., Lichtenstein L.M. Human lung mast cells. purification and characterisation J. Immunol. 129:1982;2662-2667.
53. Sears M.R., Taylor D.R., Print C.G., Lake D.C., Li Q., Flannery E.M., Yates D.M., Lucas M.K., Herbison G.P. Regular inhaled β-agonist treatment in bronchial asthma. Lancet. 336:1990;1391-1396.
54. Spitzer W.O., Suissa S., Ernst P., Horwitz R.I., Habbick B., Cockcroft D., Boivin J.F., McNutt M., Buist A.S., Rebuck A.S. The use of β agonists and the risk of death and near death from asthma. N. Engl. J. Med. 326:1992;501-506.
55. Sullivan T.J., Parker K.L., Eisen S.A., Parker C.W. Modulation of cyclic AMP in purified rat mast cells. II. Studies on the relationship between intracellular cyclic AMP concentrations and histamine release. J. Immunol. 114:1975;1480-1485.
56. Sullivan T.J., Parker K.L., Kulczycki A., Parker C.W. Modulation of cyclic AMP in purified rat mast cells. III. Studies on the effects of concanavalin A and anti-IgE on cyclic AMP concentrations during histamine release. J. Immunol. 117:1976;713-716.
57. ++ and epinephrine or glucagon. J. Am. Chem. Soc. 79:1957;3608.
58. Svedmyr N. Action of corticosteroids on beta-adrenergic receptors. Am. Rev. Respir. Dis. 141:1990;S31-S38.
59. Tattersfield A.E. Bronchodilators new developments. Br. Med. Bull. 48:1992;51-64.
60. Tauber A.I., Kaliner M., Stechschulte D.J., Austen K.F. Immunologic release of histamine and slow reacting substance of anaphylaxis from human lung. V. Effects of prostaglandins on release of histamine. J. Immunol. 111:1973;27-32.
61. Teixera M.M., Gristwood R.W., Cooper N., Hellewell P.G. Phosphodiesterase (PDE) 4 inhibitors. anti-inflammatory drugs of the future? Trends Pharmacol. Sci. 18:1997;164-171.
62. Torphy T.J., Undem B.J. Phosphodiesterase inhibitors. new opportunities for the treatment of asthma Thorax. 46:1991;512-523.
63. Torphy T.J., Zhou H.-L., Cieslinski L.B. Stimulation of beta-adrenoceptors in a human monocyte cell line (U937) up-regulates cyclic AMP-specific phosphodiesterase activity. J. Pharmacol. Exp. Therap. 263:1992;1195-1205.
64. Turner N.C., Wood L.J., Burns F.M., Gueremy T., Souness J.E. The effect of cyclic AMP and cyclic GMP phosphodiesterase inhibitors on the superoxide burst of guinea pig peritoneal macrophages. Br. J. Pharmac. 108:1993;876-883.
65. Undem B.J., Peachell P.T., Lichtenstein L.M. Isoproterenol-induced inhibition of immunoglobulin E-mediated release of histamine and arachidonic acid metabolites from the human lung mast cell. J. Pharmacol. Exp. Ther. 247:1988;209-217.
66. Verghese M.W., McConnell R.T., Lenhard J.M., Hamacher L., Jin S.-L.C. Regulation of distinct cyclic AMP-specific phosphodiesterase (phosphodiesterase type 4) isozymes in human monocytic cells. Mol. Pharmac. 47:1995;1164-1171.
67. Wallen N., Kita H., Weiler D., Gleich G.J. Glucocorticoids inhibit cytokine-mediated eosinophil survival. J. Immunol. 147:1991;3490-3495.
68. Warner J.A., Kroegel C. Pulmonary immune cells in health and disease. mast cells and basophils Eur. Respir. J. 7:1994;1326-1341.
69. Weston M.C., Anderson N., Peachell P.T. Effects of phosphodiesterase inhibitors on human lung mast cell and basophil function. Br. J. Pharmac. 121:1997;287-295.
70. Yukawa T., Ukena D., Chanez P., Dent G., Chung K.F., Barnes P.J. Beta-adrenergic receptors on eosinophils. binding and functional studies Am. Rev. Respir. Dis. 141:1990;1446-1452.